Literature DB >> 18507366

Synthesis and biological evaluation of D-amino acid oxidase inhibitors.

Dana Ferraris1, Bridget Duvall, Yao-Sen Ko, Ajit G Thomas, Camilo Rojas, Pavel Majer, Kenji Hashimoto, Takashi Tsukamoto.   

Abstract

D-amino acid oxidase (DAAO) catalyzes the oxidation of D-amino acids including d-serine, a full agonist at the glycine site of the NMDA receptor. A series of benzo[ d]isoxazol-3-ol derivatives were synthesized and evaluated as DAAO inhibitors. Among them, 5-chloro-benzo[ d]isoxazol-3-ol (CBIO) potently inhibited DAAO with an IC50 in the submicromolar range. Oral administration of CBIO in conjunction with d-serine enhanced the plasma and brain levels of d-serine in rats compared to the oral administration of d-serine alone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507366     DOI: 10.1021/jm800200u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain.

Authors:  Jin-Miao Lu; Nian Gong; Yan-Chao Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine.

Authors:  Jesse Alt; Camilo Rojas; Krystyna Wozniak; Ying Wu; Dana Ferraris; Takashi Tsukamoto; Barbara Slusher
Journal:  Anal Biochem       Date:  2011-08-16       Impact factor: 3.365

3.  Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[11C]methoxyphenethyl)pyridazin-3(2H)-one, a 11C-labeled d-amino acid oxidase (DAAO) inhibitor for PET imaging.

Authors:  Xiaoyun Deng; Yiding Zhang; Zhen Chen; Katsushi Kumata; Richard Van; Jian Rong; Tuo Shao; Akiko Hatori; Wakana Mori; Qingzhen Yu; Kuan Hu; Masayuki Fujinaga; Hsiao-Ying Wey; Yihan Shao; Lee Josephson; Giulia Murtas; Loredano Pollegioni; Ming-Rong Zhang; Steven Liang
Journal:  Bioorg Med Chem Lett       Date:  2020-06-09       Impact factor: 2.823

4.  Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment.

Authors:  Laura Caldinelli; Gianluca Molla; Luisa Bracci; Barbara Lelli; Silvia Pileri; Pamela Cappelletti; Silvia Sacchi; Loredano Pollegioni
Journal:  Protein Sci       Date:  2010-08       Impact factor: 6.725

5.  D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.

Authors:  Camilo Rojas; Jesse Alt; Nancy A Ator; Ajit G Thomas; Ying Wu; Niyada Hin; Krystyna Wozniak; Dana Ferraris; Rana Rais; Takashi Tsukamoto; Barbara S Slusher
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

Review 6.  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.

Authors:  Kenji Hashimoto; Berend Malchow; Peter Falkai; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-01       Impact factor: 5.270

7.  Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase.

Authors:  James F Berry; Dana V Ferraris; Bridget Duvall; Niyada Hin; Rana Rais; Jesse Alt; Ajit G Thomas; Camilo Rojas; Kenji Hashimoto; Barbara S Slusher; Takashi Tsukamoto
Journal:  ACS Med Chem Lett       Date:  2012-09-16       Impact factor: 4.345

8.  Novel therapeutic drugs for neuropsychiatric disorders.

Authors:  Kenji Hashimoto
Journal:  Open Med Chem J       Date:  2010-05-27

9.  The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.

Authors:  Sean M Smith; Jason M Uslaner; Peter H Hutson
Journal:  Open Med Chem J       Date:  2010-05-27

Review 10.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.